ACIM
GMED icon

Azimuth Capital Investment Management’s Globus Medical GMED Stock Holding History

Azimuth Capital Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$763K Buy
9,658
+30
+0.3% +$2.55K 0.03% 227
2026
Q1 		$830K Sell
9,628
-30
-0.3% -$2.69K 0.03% 211
2025
Q4 		$843K Sell
9,658
-1,525
-14% -$116K 0.03% 216
2025
Q3 		$640K Buy
11,183
+575
+5% +$33.1K 0.02% 229
2025
Q2 		$626K Buy
10,608
+270
+3% +$17.4K 0.02% 228
2025
Q1 		$757K Buy
10,338
+43
+0.4% +$3.55K 0.03% 221
2024
Q4 		$851K Sell
10,295
-169
-2% -$13.3K 0.03% 215
2024
Q3 		$749K Sell
10,464
-34
-0.3% -$2.4K 0.03% 224
2024
Q2 		$719K Sell
10,498
-120
-1% -$7.17K 0.03% 224
2024
Q1 		$570K Sell
10,618
-5
-0% -$269 0.02% 236
2023
Q4 		$566K Sell
10,623
-2,010
-16% -$98K 0.03% 233
2023
Q3 		$627K Buy
12,633
+8,338
+194% +$466K 0.03% 230
2023
Q2 		$256K Buy
4,295
+150
+4% +$8.55K 0.01% 280
2023
Q1 		$235K Buy
4,145
+445
+12% +$28.5K 0.01% 286
2022
Q4 		$275K Sell
3,700
-110
-3% -$7.49K 0.01% 281
2022
Q3 		$227K Hold
3,810
– – 0.01% 289
2022
Q2 		$214K Buy
+3,810
New +$250K 0.01% 298

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Azimuth Capital Investment Management's GMED Position: Q2 2026 in Review

Azimuth Capital Investment Management increased its Globus Medical (GMED) stake by 0.31% in Q2 2026, buying an estimated $2.55K and bringing the position to 9,658 shares worth $763K. The position accounts for 0.03% of the portfolio, ranked #227.

Azimuth Capital Investment Management first reported a position in GMED in Q2 2022 and has held it in 17 quarters since. The position peaked at $851K in Q4 2024. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Azimuth Capital Investment Management held 9,658 shares of Globus Medical worth $763K as of Q2 2026.
  • Azimuth Capital Investment Management bought 30 Globus Medical shares in Q2 2026, an estimated $2.55K.
  • Globus Medical made up 0.03% of Azimuth Capital Investment Management's portfolio in Q2 2026, its #227 holding.
  • Azimuth Capital Investment Management first reported a position in Globus Medical in Q2 2022 and has held it in 17 quarters since.
  • Azimuth Capital Investment Management's Globus Medical position peaked at $851K in Q4 2024.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.